Effective and safe examination of Luseogliflozin for patients with fatty liver merger type II diabetes mellitus
Phase of Trial: Phase II
Latest Information Update: 22 Aug 2017
At a glance
- Drugs Luseogliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 19 Aug 2017 Status changed from active, no longer recruiting to completed.
- 21 Feb 2017 Status changed from recruiting to active, no longer recruiting.
- 06 Sep 2016 Status changed from not yet recruiting to recruiting.